Report Categories
View AllRecent Articles
View All
Micron on Track for Best Month Since 1987 Yet Analysts See Room to Run
Trump Postpones AI Executive Order Over Concerns It Could Have Been a Blocker
Tesla Chases Autonomous Driving Future While Stock Trades at 350x Earnings
US Productivity Growth Cools in Q4 as Labor Costs Rise at Faster Pace
New Fed Chair Kevin Warsh Faces Doom Loop of Debt and Inflation as Bond Market Signals Danger
Russia Escalates Ukraine Conflict Threatens Additional Strikes on Kyiv Urges Foreign Nationals to Depart
Proficient Auto Logistics Inc PAL Q1 2026 Earnings Massive EPS Surprise Despite Revenue Uncertainty
CNMD Q1 2026 Earnings Adjusted EPS Surpasses Consensus Shares Edge Higher
Fastly Inc FSLY Q1 2026 Earnings Solid EPS Beat Amid Revenue Gaps and Slight Stock Pullback
FHN Q1 2026 Earnings EPS Beats Estimates by 623 as Stock Edges Higher
GREE Q1 2025 Earnings NarrowerthanExpected Loss Amid Crypto Headwinds
TCBX Q1 2026 Earnings EPS Surpasses Estimates as Bank Delivers Solid BottomLine Performance
Scholar Rock SRRK Surges Nearly 7 as Biotech Momentum Builds
Entergy Mississippi Bonds EMP Edge Higher as Income Seekers Return
Aurora Cannabis ACB Slips 28 as Shares Test Key Support Zone
Virtus Stone Harbor Emerging Markets Income Fund EDF Gains Ground as YieldSeeking Investors Return
TotalEnergies TTE Slides 08 as Selling Pressure Intensifies Near Key Resistance
External Links
Technical Indicators Point to Bullish Bias in Intermediate Term
ADAG Q2 2025 Earnings EPS Miss as ClinicalStage Biotech Focuses on Pipeline Advancement
Range Capital Acquisition Corp II Warrants RNGTW Flat at 032 as Warrants Trade Near Support
FNV Q1 2026 Earnings Strong EPS Beat Signals Resilient Royalty Portfolio
Assured Guaranty Ltd AGO Q1 2026 Earnings Strong EPS Surprise of 478 Driven by Favorable Loss Development
SOS Limited Q3 2018 Earnings Significant EPS Miss Highlights Operational Challenges
John Wiley Sons Inc WLYB Q1 2026 Earnings EPS Surpasses Estimates Stock Unchanged
AEE Q1 2026 Earnings EPS Beats Estimates by 73 Shares Edge Higher
GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain
APYX Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty Shares Slip